Precision Trials

What Precision Trials does

Precision Trials AZ, LLC is a privately held, Phoenix, Arizona-based clinical trial site network founded in 2006 that conducts Phase 2-4 studies on behalf of pharmaceutical sponsors. The company operates as a network of practicing physician research groups led by Principal Investigator Valerie Sorkin-Wells, MD (Women's Health) and Principal Investigator Richard Kelly, MD (Internal Medicine), supported by sub-investigators and a Director of Operations, Ali Hamieh, with 13+ years of clinical research experience. Its therapeutic footprint spans women's health (postmenopausal symptoms, female sexual arousal disorder, contraceptive patch and ring studies, urinary tract infections), internal medicine (cardiovascular, metabolic, gastrointestinal, and renal conditions), and urology, with several additional studies in the pipeline.

The company's underlying operating model relies on existing patient databases and daily patient encounters at the participating physician practices to drive targeted, low-cost patient recruitment, supported by a central IRB for expedited study startup and by GCP- and NIH-trained physician investigators. All physician investigators are board-certified and have established large practices and referral networks, which the company cites as a structural advantage for patient enrollment. Patient volunteers receive no-cost physical exams, lab testing, study medication, and compensation for time and travel.

Commercially, Precision Trials generates revenue through professional services contracts with pharmaceutical sponsors covering protocol conduct, recruitment, regulatory reporting, budget management, and quality oversight. Pricing is quote-based and not publicly disclosed. The company markets to sponsors and patients through its website, phone, and email, and operates exclusively within a regional Phoenix, Arizona footprint. There is no evidence of institutional investment, partnerships, M&A activity, or geographic expansion in the available data.

Name

Precision Trials

Legal name

Precision Trials AZ, LLC

Website

https://precisiontrials.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Precision Trials AZ, LLC is a Phoenix, Arizona-based clinical trial site network conducting Phase 2-4 studies in women's health, urology, and internal medicine on behalf of pharmaceutical sponsors, using practicing physician groups and existing patient databases to recruit volunteers.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)

Keywords

• Clinical trial services
• Patient recruitment
• Women's health trials
• Internal medicine research
• Pharmaceutical research

Headquarters

HQ city

Phoenix

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Trial Services: Revenue generated from conducting Phase 2-4 clinical trials for pharmaceutical sponsors. Compensation based on patient enrollment, study conduct, data collection, and regulatory reporting services. The company oversees daily protocol activities, recruitment, regulatory reporting, budget, and quality oversight.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Precision Trials AZ operates a network of practicing physician research groups in Phoenix, Arizona that conducts Phase 2-4 clinical trials for pharmaceutical sponsors. The company provides two primary service lines: Women's Health trials (led by Dr. Valerie Sorkin-Wells) and Internal Medicine trials (led by Dr. Richard Kelly), covering therapeutic areas such as postmenopausal symptoms, contraception, cardiovascular disease, diabetes, hypertension, and gastrointestinal conditions. Services include protocol conduct, patient recruitment from existing databases and daily encounters, regulatory reporting, budget management, and quality oversight using a central IRB for expedited study startup.

Product overview

Precision Trials AZ operates as a network of practicing physician research groups in Phoenix, Arizona, offering Phase II-IV clinical trial services. The company provides two primary service lines: Women's Health trials (covering contraceptive patch, vaginal ring contraception, postmenopausal hot flashes, and female sexual arousal disorder) led by Valerie Sorkin-Wells MD, and Internal Medicine trials (covering cardiovascular, metabolic, and gastrointestinal conditions) led by Richard Kelly MD. The organization also provides patient volunteer recruitment and retention services, leveraging existing patient databases and daily encounters to reduce costs and maximize targeted recruitment. All services include GCP and NIH-trained investigators, regulatory reporting, budget oversight, and quality assurance.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Services - Women's Health Phase II-IV clinical trial services specializing in women's health conditions including postmenopausal vasomotor symptoms (hot flashes), female sexual arousal disorder, contraceptive patch studies, vaginal ring contraception, and uncomplicated urinary tract infections. Led by Principal Investigator Valerie Sorkin-Wells, MD. Targeted at pharmaceutical sponsors seeking qualified investigators and patient populations.
• Clinical Trial Services - Internal Medicine Phase II-IV clinical trial services for internal medicine conditions including influenza, acute coronary syndrome, coronary artery disease, diabetes, dyslipidemia, hypertension, irritable bowel syndrome, diarrhea, constipation, chronic kidney disease, and rheumatoid arthritis. Led by Principal Investigator Richard Kelly, MD. Targeted at pharmaceutical sponsors seeking qualified investigators and patient populations.
• Patient Volunteer Recruitment Services Recruitment services that attract and retain clinical trial participants from existing patient databases and daily patient encounters at the physician practices in the network. Compensation for time and travel is typically provided to volunteers. Supports pharmaceutical sponsor studies by reducing recruitment costs and maximizing targeted enrollment.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves4 records

Expansion highlights2 records

Direct peers

• Accel Research Sites: Multi-therapeutic clinical trial site network conducting Phase 2-4 studies with embedded physician investigators; operates on a similar site-management model targeting pharmaceutical sponsors.
• Wake Research: Regional-to-multi-regional U.S. site network specializing in Phase 2-4 trials across women's health, internal medicine, and other therapeutic areas — directly comparable in service offering and customer base.
• Velocity Clinical Research: Large U.S. multi-site SMO network running Phase 2-4 trials across multiple therapeutic areas; directly comparable as a competing site network that recruits from physician practice databases for pharmaceutical sponsors.
• Meridian Clinical Research: Multi-site clinical research network operating dedicated research centers alongside physician practices, with broad therapeutic expertise in vaccines, women's health, and internal medicine — directly comparable business model.
• Optimal Clinical Research: Independent U.S. site network running multi-therapeutic Phase 2-4 trials through physician investigator practices — comparable in scale, therapeutic mix, and sponsor-facing service offering.
• Benchmark Research: Independent U.S. site management organization running Phase 2-4 trials with multi-specialty physician investigators — closely comparable as a similarly-sized private SMO.
• JBR Clinical Research: Utah-based clinical research site network conducting Phase 2-4 trials for pharmaceutical sponsors across multiple therapeutic areas; comparable in operating model and sponsor relationships.

Broad incumbents

• PPD / Thermo Fisher Scientific Clinical Research: Global CRO operating one of the largest site networks (Accelerated Enrollment Solutions) for Phase 1-4 trials; comparable in that it serves pharmaceutical sponsors with site-based clinical trial conduct, though at vastly larger scale.
• Synexus (Synexus Clinical Research): Largest dedicated global SMO network, now part of a major CRO platform, operating owned clinical trial sites worldwide; comparable service line but at materially greater scale and geographic reach.
• IQVIA: Global clinical research services provider with extensive site network and site-management capabilities; competes for the same pharmaceutical-sponsor contracts as an end-to-end alternative to independent SMOs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/precision-trials-llc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision Trials